Diagnosis and differential diagnosis of multiple sclerosis;Diagnose und differentialdiagnose der multiplen sklerose

Praxis

Volumn 86, Issue 3, 1997, Pages 46-54

  Huber, S ^a   Kappos, L ^a,b  

^a Neurologische Univ Klin P   (Switzerland)

^b Neurologische Universitatsklinik Basel   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; AUTOIMMUNE DISEASE; BRAIN; BRAIN DISEASE; CEREBROSPINAL FLUID; DIFFERENTIAL DIAGNOSIS; EVOKED SOMATOSENSORY RESPONSE; GENETIC DISORDER; HUMAN; METABOLIC DISORDER; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTION AND FORECASTING; REVIEW; SARCOIDOSIS;

ADULT; AUTOIMMUNE DISEASES; BRAIN; BRAIN DISEASES; DIAGNOSIS, DIFFERENTIAL; EVOKED POTENTIALS, SOMATOSENSORY; GENETIC DISEASES, INBORN; HUMANS; MAGNETIC RESONANCE IMAGING; MEDICAL HISTORY TAKING; METABOLIC DISEASES; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PREDICTIVE VALUE OF TESTS; SARCOIDOSIS;

EID: 0031566859     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Lee K. H., Hashimoto S. A., Hooge J. P., Kastrukoff L. F., Oger J. J. F., Li D. K. B. et al.: Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis. Neurology 41, 657-660 1991.
2. Fieschi C.: The Differential Diagnosis of Multiple Sclerosis. Workshop MS-Forum 1994.
3. Weinshenker B. G., Bass B., Rice G. P. A., Noseworthy J., Carriere W., Baskerville J. et al.: The natural history of multiple sclerosis - a geographically based study. I. Clinical course and disability. Brain 112, 133-146, 1989.
4. Poser S.: Multiple Sklerose. Wissenschaftliche Buchgesellschaft, Darmstadt, S. 109, 1986.
5. Kesselring J.: Multiple Sklerose, 2. Aufl. Kohlhammer, Stuttgart, Berlin, Köln, 1993.
6. Andersson M., Alvarez-Cermeno J., Bernardi G., Cogato I., Fredman P., Frederiksen J. et al.: Cerebrospinal fluid in the diagnosis of multiple sclerosis - a consensus report. J. Neurol. Neurosurg. Psychiat, 57, 897-902 1994.
7. Kostulas V., Link H., Lefvert A.-K.: Oligoclonal IgG Bands in Cerebrospinal Fluid. Principles for Demonstration and Interpretation Based on Findings in 1114 Neurological Patients. Archs Neurol. 44, 1041-1044, 1987.
8. Confavreux C., Chaupuis-Cellier C., Arnaus P., Robert O., Aimard G., Devic M.: Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon. J. Neurol. Neurosurg. Psychiat. 49, 1308-1312, 1986.
9. McLean B., Luxton R. W., Thompson E. J.: A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isolelectric focusing and the log IgG-Index. A comparison and diagnostic applications. Brain 113, 1269-1289, 1990.
10. Thomson A.J., Brazil J., Feighery C., Whelan A., Keller J., Martin E.A.: CSF myelin basic protein in multiple sclerosis. Acta neur. scand. 577-583, 1985.
11. Young I. R., Hall A. S., Pallis C. A.: Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet II, 1063-1066, 1981.
12. Ormerod I. E. C., Miller D. H., McDonald W. J., du Boulay E. P. G. H., Rudge P., Kendall B. E. et al.: The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. Brain 110, 1579-1616, 1987.
13. Ravnborg M., Liguouri R., Christiansen P., Larsson H., Soelberg Sorertsen R.: The diagnostic reliability of magnetically evoked motor potentials in multiple sclerosis. Neurology 42, 1579-1616, 1992.
14. Newcombe J., Hawkins C. P., Henderson C. L., Palel H. A., Woodroofe M. N., Hayes G. M. el al.: Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain 114, 1013-1023, 1991.
15. Barnes D., McDonald W. I., Johnson G., Tofts P.S., London D.N.: Quantitative nuclear magnetic resonance imaging-characterization of experimental cerebral oedema. J. Neurol. Neurosurg. Psychiat. 50, 125-133, 1987.
16. Kermode A. G., Thompson A. J., Tofts P. S., MacManus D. G., Kendall B. E., Kingsley D. P. E. et al.: Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 113, 1477-1489, 1990.
17. Kappos L., Radü E. W.: Magnetische Resonanztomographie bei multipler Sklerose - eine Bestandsaufnahme. Klin. Neuroradiol 2, 83-140, 1991.
18. Hawkins C. P., Munro P.M.G., Mackenzie F., Kesselring J., Tofts P.S., du Boulay E. P. G. H. et al.: Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studies by gadolinium-DTPA and protein markers. Brain 113, 365-378, 1990.
19. Nesbit G. M., Forbes G. S., Scheithauer B.W., Okazaki H., Rodriguez M.: Multiple sclerosis - histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Neuroradiology 180, 467-474, 1991.
20. Grogsman R. I., Gonzalez-Scarano F., Atlas S. W., Galetta S., Silberberg D. H.: Multiple sclerosis - gadolinium enhancement in MR imaging. Radiology 161, 721-725, 1986.
21. Miller D. H., Rudge P., Johnson G., Kendall B, E., MacManus D. G., Moseley I. F. et al.: Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 11, 927-939, 1988.
22. Barkhof F., Scheltens P., Frequin S. T. F. M., Nauta J.J. P., Tas M. W., Valk J. et al.: Relapsing-remitting multiple sclerosis - sequential enhanced MR Imaging vs clinical findings in determining disease activity. AJR 159, 1041-1047, 1992.
23. Kappos L., Gold R., Hafmann E., Keil W., Clauss W.: Multiple sclerosis - diagnostic criteria and the role of contrast-enhanced MRI. In: Contrast media in MRI, Bydder G., Felix R., Bücheler E., Drayer B., Niendorf H. P., Takahashi M. et al. Medicom, Busum, 127-135, 1990.
24. Thomas D.J., Pennock J. M., Hajnal J. V., Young I. R., Bydder G. M., Steiner R. E.: Magnetic resonance imaging of spinal cord in multiple sclerosis by fluid-attenuated inversion recovery. Lancet 341, 593-594, 1993.
25. Thorpe J. W., Kidd D., Kendall B. E., Tofts P. S., Barker G. J., Thompson A. J. et al.: Spinal cord MRI using multi-array coils and fast spin echo I. Technical aspects and findings in healthy adults. Neurology 43, 2625-2631, 1993.
26. Thorpe J. W., Kidd D., Moseley I. E, Thompson A. J., MacManus D. G., Compston D. A. S. et al.: Spinal multiple sclerosis, a clinical and MRI study. Brain, 1996 (in press).
27. Miller D. H., McDonald W. I., Blumhardt L. D., du Boulay E. P. G. H., Halliday A. M.: Magnetic resonance imaging in isolated non-compressive spinal cord syndromes. Ann. Neurol. 22, 714-723, 1987.
28. Thorpe J. W., Kidd D., Moseley I. F., Kendall B. E., Thompson A. J., MacManus D. G. et al.: Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46, 373-378, 1996.
29. Stöhr M.: Klinische und elektrodiagnostische Konsequenzen der Impulsleitungsstörungen bei demyelinisierenden Prozessen. In: Evozierte Potentiale, Stöhr M., Dichgans J., Diener H.C., Buettner U.W. (eds.). Springer-Verlag, Berlin, Heidelberg; 1989:
30. Schumacher G. A., Beebe G. W., Kibler R. F., Kurland L. T, Kurtzke J. F., McDowell F. et al.: Problems of experimental trials of therapy in multiple sclerosis - report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann. N.Y. Acad. Sci. 122, 552-568, 1965.
31. Poser C. M., Paty D. W., Scheinberg L. C., McDonald W.I., Davis F. A., Ebers G. C. et al.: New diagnostic criteria for multiple sclerosis - guidelines for research protocols. Ann. Neurol. 13, 227-231, 1983.
32. Lublin F. D., Reingold S. C. for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the Clinical Course of Multiple Sclerosis. Results of an International Survey. Neurology 46, 907-911, 1996.
33. Poser C. M.: Onset symptoms of multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 58, 253-254, 1995.
34. Morrissey S. P., Miller D. H., Kendall B. E., Kingsley D. P. E., Kelly M. A., Francis D. A. et al.: The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 116, 135-146, 1993.
35. Halperin J. J., Volkman D. J., Wu P.: Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 41, 1571-1582, 1991.
36. Halperin J. J.: Neuroborreliosis. Am. J. Med. 98, 52-59, 1995.
37. Baumgartner E, Friedli P, Erard P, Käser P.: Les manifestations neurologiques de la maladie de Lyme. Revue méd. Suisse romande 113, 873-884, 1993.
38. Diener H. C., Dichgans J.: Wertigkeit der somatosensorisch visuell und akustisch evozierten Potentiale in der Diagnostik der multiplen Sklerose. In: Evozierte Potentiale. Stöhr M., Dichgans J., Diener H. C., Buettner U.W. (eds.). Springer-Verlag, Berlin, Heidelberg; 1989.
39. Hook E. W., Mara C. M.: Acquired syphilis in adults. New Engl. J. Med. 326, 1060-1069, 1992.
40. Prange H. W., Bobis-Seidenschtvanz I.: Zur Evaluierung serologischer Aktivitätskriterien bei Neurosyphilis. Verh. dt. Ges. Neurol. 8, 789-791, 1994.
41. Stingl B., Hänny P., Waespe W.: Neurolues 1982-1989. Schweiz. med. Wschr. 120, 1575-1583, 1990.
42. Bussone G., La Manita L., Grazzi L., Lumperti E., Salmaggi A., Strada L.: Neurobrucellosis Mimicking Multiple Sclerosis. A case report. Eur. Neurol. 28, 238-240, 1989.
43. Berger J. K., Sheremata W. A., Resnick L, Atherton S., Fletcher M. A., Norenber M.: Multiple sclerosis-like illness occurring with human immunodeficiency virus infection. Neurology 39, 324-329, 1989.
44. Berger J. R., Tornatore C., Major E. O., Brace J., Shapshak P., Yoshioka M. et al.: Relapsing and remitting human immunodeficiency virus-associated leukoencephalomyelopathy. Ann. Neurol. 31, 34-38, 1992.
45. Trotot P., Vazeux R., Yamashita H. K.: MRI pattern of progressive multifocal leukoencephalopathy P. M. L. in AIDS. J. Neuroradiol. 17, 254, 1990
46. Berger J. R., Kaszovitz B., Donovan J., Dickinson G.: Progressive Multifocal Leukoencephalopathy Associated with Human Immunodeficiency Virus Infection. A review of literature with a report of 16 cases. Ann. Intern. Med. 107, 78-87, 1987.
47. Moore G. R. W., Traugott U., Scheinbeg L. C., Raine C. S.: Tropical Spastic Paraparesis. A model of virus-induced cytotoxic T-cell mediated demyelination? Ann. Neurol. 26, 523-530, 1989.
48. Shibasaki H., Endo C., Kuroda Y., Kakigi R., Oda K.-I., Komine S.-I.: Clinical picture of HTLV-1 associated myelopathy. J. neurol. Sci. 87, 15-24, 1988.
49. Tournier-Lasserve E., Gout O., Gessain A., lbaZizen M., Lyon-Caen O., Lhermitte F. et al.: HTLV-1 brain abnormalities on magnetic resonance imaging and relation with multiple sclerosis. Lancet II, 49-50, 1987.
50. Alexander E. L., Malinow K. L., Lijewski J. E.: Primary Sjörgen's syndrome with central nervous system disease mimicking multiple sclerosis. Ann. intern. Med. 104, 323-330, 1986.
51. Alexander E. L., Beall S.S., Gordon B.: Magnetic resonance imaging of cerebral lesions in patients with the Sjörgen's syndrome. Ann. intern. Med. 108, 815-823, 1988.
52. Moll J. W. B., Markusse H. M., Pijnenburg J. J. J. M., Vecht C. J., Henzen-Logmans S. C.: Antineuronal antibodies in patients with neurologic complications of primary Sjögren's syndrome. Neurology 43, 2574-2581, 1993.
53. Mills J. A.: Systemic lupus erythematosus. New Engl. J. Med. 330, 1871-1879, 1994.
54. Miller D. H., Buchanan N., Barker G., Morrissey S. P., Kendall B. E., Rudge P. et al.: Gadoliniumenhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus. J. Neurol. 239, 460-464, 1992.
55. Barned S., Goodman A. D., Mattson D. H.: Frequency of anti-nuclear antibodies in multiple sclerosis. Neurology 45, 384-385, 1995.
56. Hughes G.R. V., Harris N. N., Gharavi A. E.: The Anticardiolipin Syndrome. J. Rheumatol. 13, 486-489, 1986.
57. Wechsler B., Vidailhet M., Piette P. C., Bousser M. G., Dell'Isola B., Blétry O. et al.: Cerebral venous thrombosis in Behçet's disease. Clinical study and long-term follow-up of 25 cases. Neurology 42, 614-618, 1992.
58. Serdaroglu P., Yazici H., Özdemir C., Yurdakul S.. Baher S., Aktin E.: Neurological involvement in Behçet's syndrome. A prospective study. Arch. Neurol. 46, 265-269, 1989.
59. Wechsler B., Dell'Isola B., Vidailhel M., Dormant D., Pierre J. C., Biétry O. et al.: MRI in 31 patients with Behçet's disease and neurological involvement: prospective study with clincal correlation. J. Neurol. Neurosurg. Psychiat. 56, 793-798, 1993.
60. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 335, 1078-1080, 1990.
61. Kesselring J., Miller D.H., Robb S.A., Kendall B. E., Moseley I. F., Kingsley D. et al.: Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain 113, 291-302, 1990.
62. Caldemeyer K. S., Smith R. R., Harris T. M., Edwards M. K.: MRI in acute disseminated encephalomyelitis. Neuroradiology 36, 216-220, 1994.
63. Oksanen V.: Neurosarcoidosis. Sarcoidosis 11, 76-79, 1994.
64. Smith A., Meisler D. M., Weinstein M. A., Tomsak R. L., Hanson M. R., Rudick R. A. et al.: High-signal periventricular lesions in patients with sarcoidosis. Neurosarcoidosis or multiple sclerosis. Am. J. Neuroradiol. 10, 485-490, 1989.
65. McLean B. N., Milthell D. N., Thompson E.J.: Local synthesis of specific IgG in the cerebrospinal fluid of patients with neurosarcoidosis detected by antigen immunoblotting using Kveim material. J. neurol. Sci, 99, 165-175, 1990.
66. Berger J. R., Quencer R.: Reversible myelopathy with pernicious anemia: clinical/MR correlation. Neurology 41, 947-948, 1991.
67. . Savage D. G., Lindenbaum J., Stabler S. P., Allen R. H.: Sensitivity of serum methylmalonic acid and total homcystein determinations for diagnosing cobalamin and folate deficiency. Am. J. Med. 96, 239-246, 1994.
68. 12 deficiency. Arch. Neurol. 48, 808-811, 1991.
69. Goodkin D. E., Jacobsen D. W., Galvez N., Daughtry M., Secic M., Green R.: Serum cobalamin deficiency is uncommon in multiple sclerosis. Arch. Neurol. 51, 1110-1114, 1994.
70. Gold R., Hunnemann D. H., Kappos L., Hanefeld F.: Adrenoleukodystrophie: Die Bedeutung einer peroxisomalen Erkrankung in der Erwachsenenneurologie. Nervenarzt 61, 72-82, 1990.
71. Klemm E., Zierz S.: Adrenoleukodystrophie und Adrenomyeloneuropathie - klinisches Spektrum, elektroyphysiologischc und biochemische Befunde bei 4 Familien. Nervenarzt 61, 219-224, 1990.
72. Stöckler S., Millner M., Molzer B., Ebner F., Körner E., Moser H. W.: Multiple-sclerosis-like syndrome in a woman heterozygous for adrenoleukodystrophy. Eur. Neurol. 33, 390-392, 1993.
73. Otto V., Reilmann L.: Frühveränderungen in der Kernspintomographie bei der Adrenoleukomyeloneuropathie. Nervenarzt 65, 264-266, 1994.
74. Damian M.S., Reichmann H., Seibel P., Bachmann G., Schachenmayr W., Dorndorf W.: Das MELAS-Syndrom. Nervenarzt 65, 258-263, 1994.
75. Kellar-Wood H., Robertson N., Govan G. G., Compston D. A. S., Harding A. E.: Leber's Hereditary Optic Neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann. Neurol. 36, 109-112, 1994.
76. Dürr A., Brice A., Seradaru M., Rancurel G., Derouesné C, Lyon-Caen O. et al.: The phenotype of "pure" autosomal dominant spastic paraplegia. Neurology 44, 1274-1277, 1994.
77. Hellwig D., Bauer B. L., List-Hellwig E., Rossberg C., Mennell H. D.: Das primär zerebrale Lymphom. Zentrbl. Neurochir. 65, 99-109, 1993.
78. Wick M. R., Mills S. E.: Intravascular-lymphomatosis: clinicopathologic features and differential diagnosis. Semin. Diagn. Pathol. 8, 91-101, 1991.
79. Weiller C., Menges C., Seiler U.: Multiple Sklerose und subkortikale arteriosklerotische Enzephalopathie in der klinischen Differenzialdiagnose. Nervenarzt 63: 746-750, 1992.
80. Mandler R. N., Davis L. E., Jeffery D. R., Kornfeld M.: Devic's neuromyelitis opitca: a clinicopathological study of eight patients. Ann. Neurol. 34, 162-168, 1993.
81. Rudick R.A., Schiffer R.S., Schwetz K.M., Herndon R. M.: Multiple sclerosis, the problem of incorrect diagnosis. Archs Neurol. 43, 578-583, 1986.
82. Fieschi C, Gasperini C., Ristori G., Bastianello S., Girmenia F., Leuzzi V. et al.: Patients with clinically definite multiple sclerosis, white matter abnormalities on MRI, and normal CSF. If not multiple sclerosis, what is it? J. Neurol. Neurosurg. Psychiat. 58, 255-256, 1995.